Want to join the conversation?
$SFM said its BoD authorized on Sept. 6, 2016 a $250MM common stock share repurchase program. The company had completed its previous $150MM share repurchase authorization during 2Q16 and currently has about 148.5MM shares of common stock outstanding. The $250MM authorization represents about 7.4% of common shares outstanding at current stock price.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.